Artery/Vein Specification Is Governed by Opposing Phosphatidylinositol-3 Kinase and MAP Kinase/ERK Signaling
- 11 July 2006
- journal article
- research article
- Published by Elsevier BV in Current Biology
- Vol. 16 (13), 1366-1372
- https://doi.org/10.1016/j.cub.2006.05.046
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injuryJCI Insight, 2005
- Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctationNature Biotechnology, 2004
- The Notch target genes Hey1 and Hey2 are required for embryonic vascular developmentGenes & Development, 2004
- Molecular regulation of vessel maturationNature Medicine, 2003
- Arteries and veins: making a difference with zebrafishNature Reviews Genetics, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- Gridlock signalling pathway fashions the first embryonic arteryNature, 2001
- An Inhibitory Role of the Phosphatidylinositol 3-Kinase-signaling Pathway in Vascular Endothelial Growth Factor-induced Tissue Factor ExpressionOnline Journal of Public Health Informatics, 2001
- Hyperproliferation and Defects in Epithelial Polarity upon Conditional Ablation of α-Catenin in SkinCell, 2001
- Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and StaurosporineMolecular Cell, 2000